 | • レポートコード：QYR2104Z5926 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、獣医用ワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（不活化ワクチン、弱毒生ワクチン、結合型ワクチン、トキソイドワクチン、組換えワクチン、DNAワクチン、その他）、用途別市場規模（獣医クリニック、獣医病院、獣医研究所、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・獣医用ワクチンの市場動向 ・企業の競争状況、市場シェア ・獣医用ワクチンの種類別市場規模（不活化ワクチン、弱毒生ワクチン、結合型ワクチン、トキソイドワクチン、組換えワクチン、DNAワクチン、その他） ・獣医用ワクチンの用途別市場規模（獣医クリニック、獣医病院、獣医研究所、小売薬局、その他） ・獣医用ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・獣医用ワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・獣医用ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・獣医用ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・獣医用ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Elanco、Merck、Merial、Zoetis、Advaxis、AmpliPhi Biosciences、Aratana Therapeutics、ARKO Labs、Bayer、CanFel Therapeutics、Ceva Animal Health、Colorado Serum、Epitopix、Genus、Hygieia Biological Laboratories、ImmuCell、Nexvet、Nuovo Biologics、UBI、Valneva、Vetoquinol、Virbac） ・結論 |
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
Market Analysis and Insights: Global Veterinary Vaccines Market
The global Veterinary Vaccines market size is projected to reach US$ 10800 million by 2026, from US$ 6692.6 million in 2019, at a CAGR of 7.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Vaccines market.
Global Veterinary Vaccines Scope and Market Size
Veterinary Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Others
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
Zoetis
Advaxis
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2016-2027)
2.2 Veterinary Vaccines Growth Trends by Regions
2.2.1 Veterinary Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Veterinary Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Veterinary Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Veterinary Vaccines Industry Dynamic
2.3.1 Veterinary Vaccines Market Trends
2.3.2 Veterinary Vaccines Market Drivers
2.3.3 Veterinary Vaccines Market Challenges
2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Revenue
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2016-2021)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2020
3.5 Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2022-2027)
5 Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Veterinary Vaccines Market Size (2016-2027)
6.2 North America Veterinary Vaccines Market Size by Type
6.2.1 North America Veterinary Vaccines Market Size by Type (2016-2021)
6.2.2 North America Veterinary Vaccines Market Size by Type (2022-2027)
6.2.3 North America Veterinary Vaccines Market Size by Type (2016-2027)
6.3 North America Veterinary Vaccines Market Size by Application
6.3.1 North America Veterinary Vaccines Market Size by Application (2016-2021)
6.3.2 North America Veterinary Vaccines Market Size by Application (2022-2027)
6.3.3 North America Veterinary Vaccines Market Size by Application (2016-2027)
6.4 North America Veterinary Vaccines Market Size by Country
6.4.1 North America Veterinary Vaccines Market Size by Country (2016-2021)
6.4.2 North America Veterinary Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2016-2027)
7.2 Europe Veterinary Vaccines Market Size by Type
7.2.1 Europe Veterinary Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Veterinary Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Veterinary Vaccines Market Size by Type (2016-2027)
7.3 Europe Veterinary Vaccines Market Size by Application
7.3.1 Europe Veterinary Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Veterinary Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Veterinary Vaccines Market Size by Application (2016-2027)
7.4 Europe Veterinary Vaccines Market Size by Country
7.4.1 Europe Veterinary Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Veterinary Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Veterinary Vaccines Market Size by Type
8.2.1 Asia-Pacific Veterinary Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Veterinary Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Veterinary Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Veterinary Vaccines Market Size by Application
8.3.1 Asia-Pacific Veterinary Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Veterinary Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Veterinary Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Veterinary Vaccines Market Size by Region
8.4.1 Asia-Pacific Veterinary Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Veterinary Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size (2016-2027)
9.2 Latin America Veterinary Vaccines Market Size by Type
9.2.1 Latin America Veterinary Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Veterinary Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Veterinary Vaccines Market Size by Type (2016-2027)
9.3 Latin America Veterinary Vaccines Market Size by Application
9.3.1 Latin America Veterinary Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Veterinary Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Veterinary Vaccines Market Size by Application (2016-2027)
9.4 Latin America Veterinary Vaccines Market Size by Country
9.4.1 Latin America Veterinary Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Veterinary Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Veterinary Vaccines Market Size by Type
10.2.1 Middle East & Africa Veterinary Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Veterinary Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Veterinary Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Veterinary Vaccines Market Size by Application
10.3.1 Middle East & Africa Veterinary Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Veterinary Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Veterinary Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Veterinary Vaccines Market Size by Country
10.4.1 Middle East & Africa Veterinary Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Introduction
11.1.4 Elanco Revenue in Veterinary Vaccines Business (2016-2021)
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Introduction
11.2.4 Merck Revenue in Veterinary Vaccines Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Introduction
11.3.4 Merial Revenue in Veterinary Vaccines Business (2016-2021)
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Introduction
11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2016-2021)
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Introduction
11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2016-2021)
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Details
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2016-2021)
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Details
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2016-2021)
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Details
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Introduction
11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2016-2021)
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Introduction
11.9.4 Bayer Revenue in Veterinary Vaccines Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Details
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2016-2021)
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Details
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2016-2021)
11.11.5 Ceva Animal Health Recent Development
11.12 Colorado Serum
11.12.1 Colorado Serum Company Details
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Introduction
11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2016-2021)
11.12.5 Colorado Serum Recent Development
11.13 Epitopix
11.13.1 Epitopix Company Details
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Introduction
11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2016-2021)
11.13.5 Epitopix Recent Development
11.14 Genus
11.14.1 Genus Company Details
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Introduction
11.14.4 Genus Revenue in Veterinary Vaccines Business (2016-2021)
11.14.5 Genus Recent Development
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Details
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2016-2021)
11.15.5 Hygieia Biological Laboratories Recent Development
11.16 ImmuCell
11.16.1 ImmuCell Company Details
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Introduction
11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2016-2021)
11.16.5 ImmuCell Recent Development
11.17 Nexvet
11.17.1 Nexvet Company Details
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Introduction
11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2016-2021)
11.17.5 Nexvet Recent Development
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Details
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2016-2021)
11.18.5 Nuovo Biologics Recent Development
11.18 UBI
.1 UBI Company Details
.2 UBI Business Overview
.3 UBI Veterinary Vaccines Introduction
.4 UBI Revenue in Veterinary Vaccines Business (2016-2021)
.5 UBI Recent Development
11.20 Valneva
11.20.1 Valneva Company Details
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Introduction
11.20.4 Valneva Revenue in Veterinary Vaccines Business (2016-2021)
11.20.5 Valneva Recent Development
11.21 Vetoquinol
11.21.1 Vetoquinol Company Details
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Introduction
11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2016-2021)
11.21.5 Vetoquinol Recent Development
11.22 Virbac
11.22.1 Virbac Company Details
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Introduction
11.22.4 Virbac Revenue in Veterinary Vaccines Business (2016-2021)
11.22.5 Virbac Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inactivated Vaccines
Table 3. Key Players of Live Attenuated Vaccines
Table 4. Key Players of Conjugate Vaccines
Table 5. Key Players of Toxoid Vaccines
Table 6. Key Players of Recombinant Vaccines
Table 7. Key Players of DNA Vaccines
Table 8. Key Players of Others
Table 9. Global Veterinary Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Veterinary Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Veterinary Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Veterinary Vaccines Market Share by Regions (2016-2021)
Table 13. Global Veterinary Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Veterinary Vaccines Market Share by Regions (2022-2027)
Table 15. Veterinary Vaccines Market Trends
Table 16. Veterinary Vaccines Market Drivers
Table 17. Veterinary Vaccines Market Challenges
Table 18. Veterinary Vaccines Market Restraints
Table 19. Global Veterinary Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Veterinary Vaccines Market Share by Players (2016-2021)
Table 21. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccines as of 2020)
Table 22. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Veterinary Vaccines Product Solution and Service
Table 26. Date of Enter into Veterinary Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Veterinary Vaccines Revenue Market Share by Type (2016-2021)
Table 30. Global Veterinary Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Veterinary Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Veterinary Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Veterinary Vaccines Revenue Market Share by Application (2016-2021)
Table 34. Global Veterinary Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Veterinary Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Veterinary Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Veterinary Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Veterinary Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Veterinary Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Veterinary Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Veterinary Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Veterinary Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Veterinary Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Veterinary Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Veterinary Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Veterinary Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Veterinary Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Veterinary Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Veterinary Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Veterinary Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Veterinary Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Veterinary Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Veterinary Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Veterinary Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Veterinary Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Veterinary Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Veterinary Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Veterinary Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Veterinary Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Veterinary Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Veterinary Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 66. Elanco Company Details
Table 67. Elanco Business Overview
Table 68. Elanco Veterinary Vaccines Product
Table 69. Elanco Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 70. Elanco Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Veterinary Vaccines Product
Table 74. Merck Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Merial Company Details
Table 77. Merial Business Overview
Table 78. Merial Veterinary Vaccines Product
Table 79. Merial Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 80. Merial Recent Development
Table 81. Zoetis Company Details
Table 82. Zoetis Business Overview
Table 83. Zoetis Veterinary Vaccines Product
Table 84. Zoetis Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 85. Zoetis Recent Development
Table 86. Advaxis Company Details
Table 87. Advaxis Business Overview
Table 88. Advaxis Veterinary Vaccines Product
Table 89. Advaxis Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 90. Advaxis Recent Development
Table 91. AmpliPhi Biosciences Company Details
Table 92. AmpliPhi Biosciences Business Overview
Table 93. AmpliPhi Biosciences Veterinary Vaccines Product
Table 94. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 95. AmpliPhi Biosciences Recent Development
Table 96. Aratana Therapeutics Company Details
Table 97. Aratana Therapeutics Business Overview
Table 98. Aratana Therapeutics Veterinary Vaccines Product
Table 99. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 100. Aratana Therapeutics Recent Development
Table 101. ARKO Labs Company Details
Table 102. ARKO Labs Business Overview
Table 103. ARKO Labs Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 104. ARKO Labs Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Business Overview
Table 107. Bayer Veterinary Vaccines Product
Table 108. Bayer Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 109. Bayer Recent Development
Table 110. CanFel Therapeutics Company Details
Table 111. CanFel Therapeutics Business Overview
Table 112. CanFel Therapeutics Veterinary Vaccines Product
Table 113. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 114. CanFel Therapeutics Recent Development
Table 115. Ceva Animal Health Company Details
Table 116. Ceva Animal Health Business Overview
Table 117. Ceva Animal Health Veterinary Vaccines Product
Table 118. Ceva Animal Health Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 119. Ceva Animal Health Recent Development
Table 120. Colorado Serum Company Details
Table 121. Colorado Serum Business Overview
Table 122. Colorado Serum Veterinary Vaccines Product
Table 123. Colorado Serum Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 124. Colorado Serum Recent Development
Table 125. Epitopix Company Details
Table 126. Epitopix Business Overview
Table 127. Epitopix Veterinary Vaccines Product
Table 128. Epitopix Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 129. Epitopix Recent Development
Table 130. Genus Company Details
Table 131. Genus Business Overview
Table 132. Genus Veterinary Vaccines Product
Table 133. Genus Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 134. Genus Recent Development
Table 135. Hygieia Biological Laboratories Company Details
Table 136. Hygieia Biological Laboratories Business Overview
Table 137. Hygieia Biological Laboratories Veterinary Vaccines Product
Table 138. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 139. Hygieia Biological Laboratories Recent Development
Table 140. ImmuCell Company Details
Table 141. ImmuCell Business Overview
Table 142. ImmuCell Veterinary Vaccines Product
Table 143. ImmuCell Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 144. ImmuCell Recent Development
Table 145. Nexvet Company Details
Table 146. Nexvet Business Overview
Table 147. Nexvet Veterinary Vaccines Product
Table 148. Nexvet Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 149. Nexvet Recent Development
Table 150. Nuovo Biologics Company Details
Table 151. Nuovo Biologics Business Overview
Table 152. Nuovo Biologics Veterinary Vaccines Product
Table 153. Nuovo Biologics Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 154. Nuovo Biologics Recent Development
Table 155. UBI Company Details
Table 156. UBI Business Overview
Table 157. UBI Veterinary Vaccines Product
Table 158. UBI Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 159. UBI Recent Development
Table 160. Valneva Company Details
Table 161. Valneva Business Overview
Table 162. Valneva Veterinary Vaccines Product
Table 163. Valneva Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 164. Valneva Recent Development
Table 165. Vetoquinol Company Details
Table 166. Vetoquinol Business Overview
Table 167. Vetoquinol Veterinary Vaccines Product
Table 168. Vetoquinol Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 169. Vetoquinol Recent Development
Table 170. Virbac Company Details
Table 171. Virbac Business Overview
Table 172. Virbac Veterinary Vaccines Product
Table 173. Virbac Revenue in Veterinary Vaccines Business (2016-2021) & (US$ Million)
Table 174. Virbac Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Inactivated Vaccines Features
Figure 3. Live Attenuated Vaccines Features
Figure 4. Conjugate Vaccines Features
Figure 5. Toxoid Vaccines Features
Figure 6. Recombinant Vaccines Features
Figure 7. DNA Vaccines Features
Figure 8. Others Features
Figure 9. Global Veterinary Vaccines Market Share by Application: 2020 VS 2027
Figure 10. Veterinary Clinic Case Studies
Figure 11. Veterinary Hospital Case Studies
Figure 12. Veterinary Research Institute Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Veterinary Vaccines Report Years Considered
Figure 16. Global Veterinary Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Veterinary Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Veterinary Vaccines Market Share by Regions: 2020 VS 2027
Figure 19. Global Veterinary Vaccines Market Share by Regions (2022-2027)
Figure 20. Global Veterinary Vaccines Market Share by Players in 2020
Figure 21. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccines as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2020
Figure 23. Global Veterinary Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Veterinary Vaccines Revenue Market Share by Type (2022-2027)
Figure 25. North America Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Veterinary Vaccines Market Share by Type (2016-2027)
Figure 27. North America Veterinary Vaccines Market Share by Application (2016-2027)
Figure 28. North America Veterinary Vaccines Market Share by Country (2016-2027)
Figure 29. United States Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Veterinary Vaccines Market Share by Type (2016-2027)
Figure 33. Europe Veterinary Vaccines Market Share by Application (2016-2027)
Figure 34. Europe Veterinary Vaccines Market Share by Country (2016-2027)
Figure 35. Germany Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Veterinary Vaccines Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Veterinary Vaccines Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Veterinary Vaccines Market Share by Region (2016-2027)
Figure 45. China Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Veterinary Vaccines Market Share by Type (2016-2027)
Figure 53. Latin America Veterinary Vaccines Market Share by Application (2016-2027)
Figure 54. Latin America Veterinary Vaccines Market Share by Country (2016-2027)
Figure 55. Mexico Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Veterinary Vaccines Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Veterinary Vaccines Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Veterinary Vaccines Market Share by Country (2016-2027)
Figure 61. Turkey Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Veterinary Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 66. Merial Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 67. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 68. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 69. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 70. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 71. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 72. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 73. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 74. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 75. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 76. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 77. Genus Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 78. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 79. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 80. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 81. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 82. UBI Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 83. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 84. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 85. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
世界のワクチン＆ワクチン接種市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines & Vaccination Market The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界の細菌ワクチン市場規模・現状・予測（2021年-2027年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- 世界のワクチン配達市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の組換えワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…